Company Overview

Development Stage

About the Company

Wuhan Naci Biotechnology Co., Ltd. (hereinafter referred to as "Naci Biotechnology" or "the Company") is a national high-tech biotechnology enterprise integrating R&D, production, sales, and technical services. Founded in January 2017 and located in the Optics Valley Biolake, a biotech industry base, the Company is committed to providing high-quality products and services for the development of China's biotechnology industry, backed by strong R&D capabilities and an excellent team.
Since 2017, the Company has conducted in-depth research in multiple areas targeting the industry demand for sample processing and automated nucleic acid extraction. It has established a complete independent intellectual property system in the R&D and production of sample pre-processing. With over 20 patent applications, including 2 invention patents, the Company has developed fully automated nucleic acid extraction instruments and multiple nucleic acid extraction reagents for different sample types, achieving parallel development of instruments and consumables, and providing comprehensive services to the in vitro diagnostics industry.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (29 open positions)

Manage
Note: How fast is hiring at Wuhan Naci Biotechnology Co., Ltd. growing? 2026: 48 openings (up 129%), 2025: 21 openings (down 72%), 2024: 75 openings (up 3%), 2023: 73 openings (up 192%), 2022: 25 openings (down 43%), 2021: 44 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2025 — 4 fewer jobs than 2024
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Wuhan Naci Biotechnology Co., Ltd. growing? Master's recruitment over the years: 2025: 1 openings (down 72%), 2024: 5 openings (up 3%), 2023: 15 openings (up 192%), 2022: 3 openings (down 43%).

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Wuhan Naci Biotechnology Co., Ltd. growing? Doctorate recruitment over the years: 2026: 1 openings (up 129%), 2024: 1 openings (up 3%), 2023: 2 openings (up 192%), 2022: 2 openings (down 43%).

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Wuhan Naci Biotechnology Co., Ltd.? Based on an analysis of 's job postings over the past year, "计算机/网络/技术类" demand: 35.9%, "其他(研发和技术类)": 18.8%, "生物/制药/化工/环保类": 14.1%, "机械/仪器仪表类": 10.9%, "医疗卫生/美容保健类": 9.4%, "电子/电器/通信技术类": 6.3%. For reference only.

— What Are the Salaries Like? (64 records)

Manage
salary range: 3K - 50K, 50% of roles pay ¥6-10K
Note: salary statistics are based on 64 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Wuhan Naci Biotechnology Co., Ltd.?50% of positions earn 6-10K, Undergraduate salary: ¥。计算机/网络/技术类 average salary ¥19.4K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Wuhan Naci Biotechnology Co., Ltd.? We provide: 销售,大客户,医疗器械,硬件,qc,开发工程师,税务,项目助理,python,嵌入式,试剂研发,会计,前端,技术支持,消防,电工,研发工程师,结构工程,质检,项目经理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 计算机/网络/技术类
    34.8% of total 34.8%
  • 其他(研发和技术类)
    18.2% of total 18.2%
  • 销售类
    18.2% of total 18.2%
  • 生物/制药/化工/环保类
    13.6% of total 13.6%

Education

  • 本科
    53% of total 53%
  • 大专
    30.3% of total 30.3%
  • 硕士
    6.1% of total 6.1%
  • 高中
    4.5% of total 4.5%

Experience

  • 1-3年
    43.9% of total 43.9%
  • 3-5年
    21.2% of total 21.2%
  • 不限
    18.2% of total 18.2%
  • 5-10年
    16.7% of total 16.7%
View Detailed Analysis

What does Wuhan Naci Biotechnology Co., Ltd. require? Who is Wuhan Naci Biotechnology Co., Ltd. hiring? recruitment: 计算机/网络/技术类占比最多占34.8%,其次是其他(研发和技术类)占18.2%. What education can get in at ? 本科占比最多占53%,其次是大专占30.3%. High education required at ? 硕士占6.1%,博士占1.5%. Work experience required at ? 1-3年占比最多占43.9%,其次是3-5年占21.2%. Where are the job locations at ? 武汉占比最多占98.5%,其次是深圳占1.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 318万(元)
Legal Representative: 潘超
Date Established:
Credit Code: 91420100MA4KQHLR58
Registered Address: 湖北省武汉市东湖新技术开发区神墩四路666号A栋18楼(自贸区武汉片区)

Partners & Suppliers

武汉纳磁生物科技有限公司向其供应自动化核酸提取仪及配套试剂,用于大规模核酸检测。 Source
合作客户 第三方检测
武汉纳磁生物科技有限公司为其提供磁珠法核酸提取试剂,用于新冠核酸检测。 Source
合作客户 医院
武汉纳磁生物科技有限公司向其供应核酸提取试剂盒及自动化提取仪,用于临床检测。 Source
合作客户 医院
武汉纳磁生物科技有限公司向其采购试剂瓶及其他药用包装材料。 Source
供应商 包装材料
武汉纳磁生物科技有限公司向其采购逆转录酶、DNA聚合酶等关键酶原料。 Source
供应商 酶原料

People who follow this company also follow

Competitors (Similar Companies)

知识产权代理 律师事务所/法律服务 商标申请 商标事务所
新材料 聚乙烯/PE 化工/化学 塑料合金
精密机械零部件 机械零部件 生产 机械五金加工
服装/服饰 纺织 丝绸 化纤面料
工程设计 建筑幕墙 机电设备安装 门窗
品牌策划 艺术涂料 墙面装饰产品 代理分销
离心泵 多级离心泵 自动化 生产
安全设备 呼吸防护设备 生产 安全防护
开关电源 变电站 直流/DC电源 电力
造纸/造纸厂/纸业 打印纸 文化用纸 双面胶
模具 模具设计 模具开发 硅胶
塑胶零件 塑胶零配件 眼镜 配件
电机 压缩机 制冷 制冷设备
跨境服务 金融 移动支付 电子商务
余热发电 轧钢 重工制造 型钢

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates